A storage instruction is a claim about how a particular material retains acceptable properties over time. It should be supported by evidence for the formulation and container, not borrowed from another peptide because both arrive as powders.

ICH stability guidance provides a framework for studying the effects of environmental conditions on drug substances and products. EMA: ICH Q1A(R2), stability testing The lesson for research materials is to connect every storage claim to a documented specification and a method capable of detecting relevant change.

Different stages of a product's life may need different evidence. An unopened container, material after repeated handling and a reformulated sample are not necessarily covered by the same stability study. A manufacturer's expiry statement may also address different conditions from a laboratory's in-use procedure.

A useful storage record identifies the material, lot, container, supported conditions and dates of relevant handling events. If an excursion occurs, the appropriate question is whether product-specific evidence supports continued suitability. A generic reassurance that peptides are stable should not replace that assessment.

Testing must examine properties that matter to the intended use. A material may appear unchanged while its content or impurity profile shifts. FDA's stability discussion explains the importance of a test that can distinguish degradation rather than merely detect the original material. FDA: Expiration dating and stability testing

This article deliberately provides no universal temperature, expiry period or freezing rule. Follow validated product-specific instructions and the laboratory's quality procedures. For prescribed medicines, use the actual labeling and pharmacist's guidance. The objective is a traceable conclusion about a particular material, not a convenient storage recipe applied to an entire chemical category.